Kotak Healthcare Fund · Direct · Growth
NAV
₹18.5800
as of 18 Nov 2026
Expense Ratio
0.99%
Lumpsum returns (CAGR)
- 1Y
- +32.42%
- 3Y
- —
- 5Y
- —
- Since Inception
- +23.48%
SIP returns (XIRR)
- 1Y
- +42.53%
- 3Y
- —
- 5Y
- —
- Since Inception
- +23.07%
Returns calculated from 20 November 2023 onwards due to a structural change in the scheme on that date. Earlier NAV history is preserved but excluded from multi-year return calculations. Periods spanning this date show —.
Performance Comparison
Sectoral allocation
as of 31 Oct 2026- Pharmaceuticals and Biotechnology69.63%
- Healthcare Services21.01%
- Healthcare Equipment and Supplies4.74%
- Chemicals and Petrochemicals3.58%
Each sector links to the mutual funds most exposed to it.
Thinking about Kotak Healthcare Fund · Direct · Growth?
Talk to our AMFI-registered team — free, no pressure. We'll help you see if this fund fits your goals.
Compare with Similar Funds
Fund Details
Available transactions
Portfolio holdings
portfolio shared with Kotak Healthcare Fund - Regular Plan - Growth Option
- 1Sun Pharmaceutical Industries Ltd.13.42%
- 2Divis Laboratories Ltd.10.23%
- 3Ami Organics Ltd4.88%
- 4Molbio Diagnostics Limited4.74%
- 5Torrent Pharmaceuticals Ltd.4.29%
- 6Laurus Labs Ltd4.19%
- 7Max Healthcare Institute Ltd.3.50%
- 8Apollo Hospitals Enterprise Ltd.3.24%
- 9Gland Pharma Limited3.24%
- 10Cipla Ltd.3.20%
What this fund does
Kotak Healthcare Fund · Direct · Growth invests in stocks from a specific sector or theme, offering concentrated exposure to a particular area of the economy. These funds carry sector-specific risks but can deliver significant returns when the underlying sector performs well.
About This Fund
Kotak Healthcare Fund · Direct · Growth is a Sectoral / Thematic mutual fund offered by Kotak Mahindra Mutual Fund. The fund has been operational for over 2 years. It benchmarks its performance against Nifty Healthcare Index (Total Return Index). The current expense ratio is 0.99%.